Gilead Sciences Announces 10 Percent Increase in First Quarter 2017 Dividend
February 07 2017 - 4:02PM
Business Wire
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the
Board of Directors declared an increase of 10% in the company’s
quarterly cash dividend, beginning in the first quarter of 2017.
The dividend increase will result in a quarterly dividend of $0.52
per share of common stock. The dividend is payable on March 30,
2017, to stockholders of record at the close of business on March
16, 2017. Future dividends will be subject to Board approval.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need. The company’s mission is to advance the care of
patients suffering from life-threatening diseases. Gilead has
operations in more than 30 countries worldwide, with headquarters
in Foster City, California.
For more information on Gilead Sciences, please
visit the company’s website at www.gilead.com, follow Gilead on
Twitter (@GileadSciences) or call Gilead Public Affairs at
1-800-GILEAD-5 or 1-650-574-3000.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170207006271/en/
Gilead Sciences, Inc.InvestorsRobin Washington, 650-522-5688Sung
Lee, 650-524-7792
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Apr 2023 to Apr 2024